Universal Time: 15:30  |  Local Time: 15:30 (0h GMT)
Select your timezone:

P-12 - Poster Session

Room: E-Poster Hall
Track: Liver


Hillary J Braun, United States
Late acute rejection after liver transplant is associated with increased risk of death

Dr. Shinji Onda, Japan
Successful living-donor liver transplantation for donor-specific antibody-positive recipients using rituximab

Prof. Susumu Eguchi, Japan
The first case of simultaneous deceased donor liver and kidney transplantation in an HIV/HCV co-infected patient with hemophilia in Japan

Dr. Seisuke Sakamoto, Japan
The impact of Fc-gamma receptor polymorphism on infectious complications in pediatric liver transplantation

Treatment of antibody mediated rejection after liver transplant: What do we know?

Dr. Margot Fodor, Austria
Reassessment of the relevance and predictive value of parameters indicating early graft dysfunction in liver transplantation: A retrospective single center experience

Fidel Lopez-Verdugo, United States
Thromboembolism-risk-based algorithm decreases anticoagulation rates and bleeding risk after liver transplantation

Dr. Ramkiran Cherukuru, India
Risk factors and outcomes of children with prolonged chyle leak after pediatric liver transplantation

Dr. Gustavo S Ferreira, Brazil
Impact of routine use of abdominal drains on the diagnosis, management and outcomes of liver transplant complications

Dr. Alberto Marcacuzco quinto, Spain
Risk factors for PNF after uDCD liver transplants

Dr. Masaaki Hidaka, Japan
Does external bile drainage through a T-tube increase the risk of early allograft dysfunction in whole liver transplantation?

Joo Dong Jin, Korea
Alcoholic liver disease has more bleeding tendency during liver transplant operation in low MELD patients ≤ 20

Dr. Emre Karakaya, Turkey
Management of portal venous complications after liver transplant

Dr. Svetlana Adamcova Selcanova PhD, Slovakia (Slovak Republic)
De novo non-alcoholic fatty liver disease after liver transplantation in small liver transplant centre in Slovakia

Dr. Kenji Okumura, United States
The impact of “Six-month Rule” on liver transplant outcome in patients with alcohol related liver disease

Ms. Danielle Romero, United States
Liver transplantation in infantile Navajo neurohepatopathy

Takashi Onoe, Japan
Portal hypertension increase anti-donor immune response after living donor liver transplantation in patients and mouse model

Suk Kyun Hong, Korea
Pure laparoscopic versus open right hepatectomy in live liver donors: a propensity score matched analysis

Prof. Binnaz Handan Ozdemir, Turkey
Multifactorial effect of hepatocyte growth factor (HGF) on the microscopic regeneration of liver allograft in recipients who underwent transplantation from living donors

Joo Dong Kim, Korea
Technical refinement to prevent hepatic outflow disturbance in right lobe living donor liver transplantation: Simplified one-orifice venoplasty with artificial vascular graft

Dr. Aydan Akyuz Ozdemir, Turkey
Is the merit of becoming a living liver donor enough?

Joo Dong Kim, Korea
Biliary reconstruction using high biliary radical is safe option for multiple graft bile ducts during right lobe living donor liver transplantation

Dr. Javier Serradilla, Spain
200 living donor liver transplantation in children: Outcomes and results according to indication for transplantation and graft type

Ensi Ma, People's Republic of China
Development of nomogram prediction model for postoperative recurrence of HCC patients undergoing liver transplantation in Chinese population with internal validation

Dr. Seiichi Shimizu, Japan
Risk factor and treatment for chronic antibody mediated rejection after pediatric living donor liver transplantation

Dr. Javier Serradilla, Spain
Outcome and survival of late liver retransplantation in children: A single-center experience

Suk Kyun Hong, Korea
Outcome of pediatric liver transplantation and risk factors affecting overall survival: Using two Korean national registry data

Mr. Tuo Chen, People's Republic of China
Prognostic analysis of patients underwent salvage liver transplantation within Hangzhou criteria

Dr. Yulia Malinovskaya, Russian Federation
TRANSPLANT.NET: on-line monitoring system to follow up solid-organ transplant recipients

Prof. Yang Won Nah, Korea
83% 10 year survival rate after liver transplantation in 200 cases at a small volume center in Korea

Dr. Yulia Malinovskaya, Russian Federation
Physical activity of liver recipients measured by wearable devices and obesity

Dr. Yulia Malinovskaya, Russian Federation
Late liver allograft dysfunction: Frequency, types, risk factors

Dr. Li Jianhua, People's Republic of China
AGH score predicts recurrence and response to adjuvant-targeted therapy in HBV related HCC after liver transplantation.

Liver transplantation with neoadjuvant chemoradiation for treatment of unresectable hilar cholangiocarcinoma. An European series.

Dr. Li Jianhua, People's Republic of China
NCV index is a potential predictor of MVI in patients with HCC who undergoing liver transplantation

Dr. Felipe Alconchel, Spain
PIVKA-II and biochemical parameters in patients with hepatocellular carcinoma on waiting list for liver transplantation

Jorge Sanchez-Garcia, United States
ALBI grade at 30 days after transarterial radioembolization have poor prognosis after liver transplantation

Dr. Yoshihiro Hirata, India
The impact of middle hepatic vein reconstruction in right lobe living donor liver transplantation, analysis of congestion area of anterior section and portal vein flow volume

Dr. Kyeongdeok Kim, Korea
Hepatitis B immunoglobulin prophylaxis for prevention of de novo hepatitis B infection from hepatitis B core antibody-positive donors

Dr. Chutwichai Tovikkai, Thailand
Liver transplantation in Thailand: The first report from the Thai Liver Transplant Registry

Dr. Masaaki Hidaka, Japan
Effect of pre-transplant sarcopenia on the estimation of the standard liver volume in living-donor liver transplant candidates

Ebru Hatice Ayvazoglu Soy, Turkey
Long term liver transplant survivors

Fatih Boyvat, Turkey
An effective bridging tips technique to liver transplantation for budd-chiari syndrome

Prof. Binnaz Handan Ozdemir, Turkey
Hepatocyte growth factor (HGF) prevents the apoptotic and anti-angiogenic effect of hypercholesterolemia on hepatocytes in liver allografts

Dr. Gustavo S Ferreira, Brazil
Portal and arterial reperfusion during liver transplant: A comparison between the simultaneous and sequential techniques

Fidel Lopez-Verdugo, United States
Building a self-sufficient liver transplant program in Mongolia

Dr. Neslihan Bascil Tutuncu, Turkey
Post-transplant diabetes mellitus incidence and risk factors in adult liver transplantation recipients

Dr. Shiva Kumar, United Arab Emirates
Liver transplantation in the United Arab Emirates: Initial two-year experience

Dr. Samed Rahatli, Turkey
Recurrence and the survival analysis of liver transplanted hepatocellular carcinoma patients

Mr. Haojun Wang, People's Republic of China
Association between donor and recipient gene polymorphisms and risk of new-onset neurological complications after liver transplantation

Aydincan Akdur, Turkey
Liver transplantation for primary sclerosing cholangitis

Dr. Goragoch Gesprasert, Thailand
The first report of pediatric liver transplantation in Thailand from the Thai Liver Transplant Registry

Ebru Hatice Ayvazoglu Soy, Turkey
Post liver transplant incisional hernia management

Mr. Stepan Zubenko, Russian Federation
Liver transplantation for portal vein thrombosis: Single center experience

Michael Fink, Australia
Comparison of split and whole liver transplantation for higher acuity recipients – A propensity match study

Fidel Lopez-Verdugo, United States
Living donor liver transplantation and intention to use segmental grafts increases transplant rates and decreases waiting time at a single institution

WebApp Sponsor

© 2024 TTS 2020